https://www.has-sante.fr/jcms/p_3344843/fr/ronapreve-casirivimab-/-imdevimab-prevention-de-la-covid-19 2022 false false false France COVID-19 casirivimab and imdevimab treatment outcome insurance, health, reimbursement Post-Exposure prophylaxis adult adolescent antiviral agents evaluation of the transparency committee COVID-19 casirivimab casirivimab and imdevimab drug combination imdevimab
--- https://www.has-sante.fr/jcms/p_3318295/fr/ronapreve-casirivimab-imdevimab https://www.has-sante.fr/jcms/p_3318291/fr/decision-n-2022-0066/dc/sem-du-17-fevrier-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-ronapreve 2022 false false false France casirivimab and imdevimab evaluation of the transparency committee casirivimab imdevimab casirivimab and imdevimab drug combination